1921
Volume 93, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

The incidence of hepatitis B virus (HBV) infection has been declining thanks to the universal hepatitis B infant immunization program. Nevertheless, young adults born before the program implementation might have acquired HBV in early childhood or remain susceptible to infection. This study aimed to evaluate hepatitis B epidemiology in asymptomatic young adult population in Ternate, eastern Indonesia. Serum samples of 376 subjects (aged 17–25, mean 19.82 ± 1.69 years; male/female 138/238) were screened for HBV parameters serologically (HBV surface antigen [HBsAg]; its antibody [anti-HBs]; anti-core antigen [anti-HBc]), and molecularly (HBV DNA). HBsAg, anti-HBc, anti-HBs, and HBV DNA prevalence were 15.7%, 36.2%, 24.2%, and 27.9%, respectively, with male predominance. Of all subjects, 13.0% were HBsAg negative with detectable HBV DNA (occult hepatitis B [OHB]), and 56.4% showed negativity for all seromarkers. This population showed high hepatitis B prevalence with substantial occurrence of OHB. However, a high percentage of the population were still susceptible and at risk of HBV infection. This study emphasizes the necessity to improve prevention strategies to screen and manage HBV carriers, including the adoption of catch-up or booster vaccination targeted to young adult populations. Investigations on the roles of host-virus interactions associated with OHB and its implications are warranted.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.15-0331
2015-12-09
2019-11-16
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/6/1349.html?itemId=/content/journals/10.4269/ajtmh.15-0331&mimeType=html&fmt=ahah

References

  1. WHO, 2015. Hepatitis B Fact Sheet no. 204 [updated July 2015; cited July 27, 2015]. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/. [Google Scholar]
  2. WHO, 2015. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva, Switzerland: WHO Press. [Google Scholar]
  3. Stewart BW, Wild CP, , eds, 2014. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer. [Google Scholar]
  4. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA, 3rd Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA, , 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 20952128.[Crossref] [Google Scholar]
  5. Bowden S, Lai CL, Locarnini S, , 2002. Laboratory diagnosis of hepatitis B infection. , eds. Hepatitis B Virus. London, United Kingdom: International Medical Press Ltd., 145160. [Google Scholar]
  6. Kann M, Lai CL, Locarnini S, , 2002. Structural and molecular virology. , eds. Hepatitis B Virus. London, United Kingdom: International Medical Press Ltd., 922. [Google Scholar]
  7. EASL, 2012. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57: 167185.[Crossref] [Google Scholar]
  8. Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, Amarapurkar D, Cooksley G, Jafri W, Mohamed R, Hou JL, Chuang WL, Lesmana LA, Sollano JD, Suh DJ, Omata M, , 2012. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int 6: 531561.[Crossref] [Google Scholar]
  9. Lok AS, McMahon BJ, , 2009. Chronic hepatitis B: update 2009. Hepatology 50: 661662.[Crossref] [Google Scholar]
  10. Schillie SF, Murphy TV, , 2013. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine 31: 25062516.[Crossref] [Google Scholar]
  11. Allain JP, Candotti D, , 2011. Hepatitis B virus in transfusion medicine: still a problem? Biologicals 40: 180186.[Crossref] [Google Scholar]
  12. Gerlich WH, , 2004. Diagnostic problems caused by HBsAg mutants—a consensus report of an expert meeting. Intervirology 47: 310313.[Crossref] [Google Scholar]
  13. Hollinger FB, , 2008. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 48: 10011026.[Crossref] [Google Scholar]
  14. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P, , 2001. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology 34: 194203.[Crossref] [Google Scholar]
  15. Chaudhuri V, Saxena A, Hazari S, Acharya S, Panda SK, , 2000. Hepatitis B virus in seronegative samples. Antivir Ther 5 (Suppl 1): B21. [Google Scholar]
  16. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ, , 1978. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298: 13791383.[Crossref] [Google Scholar]
  17. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF, , 1998. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38: 5659.[Crossref] [Google Scholar]
  18. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F, , 2008. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49: 652657.[Crossref] [Google Scholar]
  19. Khan M, Dong JJ, Acharya SK, Dhagwahdorj Y, Abbas Z, Jafri SMW, Mulyono DH, Tozun N, Sarin SK, , 2004. Hepatology issues in Asia: perspectives from regional leaders. J Gastroenterol Hepatol 19: S419S30.[Crossref] [Google Scholar]
  20. Mulyanto Tsuda F, Karossi AT, Soewignjo S, Roestamsjah Sumarsidi D, Trisnamurti RH, Sumardi Surayah Udin LZ, Melani-Wikanta Kanai K, Mishiro S, , 1997. Distribution of the hepatitis B surface antigen subtypes in Indonesia: implications for ethnic heterogeneity and infection control measures. Arch Virol 142: 21212129.[Crossref] [Google Scholar]
  21. Thedja MD, Muljono DH, Nurainy N, Sukowati CH, Verhoef J, Marzuki S, , 2011. Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9. Arch Virol 156: 855868.[Crossref] [Google Scholar]
  22. Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H, , 2008. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46: 21602166.[Crossref] [Google Scholar]
  23. Sugiono D, , 2008. The Mapping of Languages in Indonesia. Jakarta, Indonesia: Language Center Press. [Google Scholar]
  24. Huggett R, , 2011. Biogeographical regions. eLS.
  25. Herawati MH, , 1999. Program pengembangan imunisasi dan produk vaksin hepatitis B di Indonesia. Cermin Dunia Kedokteran 124: 2527. [Google Scholar]
  26. Lawrence MH, Goldstein MA, , 1995. Hepatitis B immunization in adolescents. J Adolesc Health 17: 234243.[Crossref] [Google Scholar]
  27. Hill H, Resosudarmo B, Vidyattama Y, , 2008. Indonesia's Changing Economic Geography. Kyoto, Japan: CCAS. [Google Scholar]
  28. Statistics Indonesia, National Population and Family Planning Board, Ministry of Health, ICF International, 2013. Indonesia Demographic and Health Survey 2012. Jakarta, Indonesia: BPS, BKKBN, Kemenkes, and ICF International. [Google Scholar]
  29. Miranti R, Resosudarmo B, , 2005. Understanding regional poverty in Indonesia: is poverty worse in the east than in the west? AJRS 11: 141154. [Google Scholar]
  30. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M, , 1992. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 63: 107111.[Crossref] [Google Scholar]
  31. Okamoto H, Nishizawa T, , 1992. Non-B non-C non-G hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus. [Google Scholar]
  32. Thedja MD, Muljono DH, Ie SI, Sidarta E, Turyadi Verhoef J, Marzuki S, , 2015. Genogeography and immune epitope characteristics of hepatitis B virus genotype C reveals two distinct types: Asian and Papua-Pacific. PLoS One 10: e0132533.[Crossref] [Google Scholar]
  33. Thedja MD, Roni M, Harahap AR, Siregar NC, Ie SI, Muljono DH, , 2010. Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int 4: 608614.[Crossref] [Google Scholar]
  34. Darmawan E, Turyadi El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH, , 2015. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia. J Med Virol 87: 199207.[Crossref] [Google Scholar]
  35. Kwok S, Higuchi R, , 1989. Avoiding false positives with PCR. Nature 339: 237238.[Crossref] [Google Scholar]
  36. Lavanchy D, , 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97107.[Crossref] [Google Scholar]
  37. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL, , 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30: 13121317.[Crossref] [Google Scholar]
  38. Oon CJ, Goh KT, Lim GK, , 1991. Clearance of neonatal antiHBc following hepatitis B vaccination: relationship to antiHBs levels. Ann Acad Med Singapore 20: 231235. [Google Scholar]
  39. Ruff TA, Gertig DM, Otto BF, Gust ID, Sutanto A, Soewarso TI, Kandun N, Marschner IC, Maynard JE, , 1995. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. J Infect Dis 171: 290296.[Crossref] [Google Scholar]
  40. Bonanni P, , 1998. Universal hepatitis B immunization: infant, and infant plus adolescent immunization. Vaccine 16 (Suppl): S17S22.[Crossref] [Google Scholar]
  41. Brookman RR, Koff RS, Schaffner W, Margolis HS, Collins M, Bloom BS, Coupey SM, , 1995. Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable. J Adolesc Health 17: 208233.[Crossref] [Google Scholar]
  42. Cassidy WM, Mahoney FJ, , 1995. A hepatitis B vaccination program targeting adolescents. J Adolesc Health 17: 224247.[Crossref] [Google Scholar]
  43. Abdel-Hady M, Kelly D, , 2013. Chronic hepatitis B in children and adolescents: epidemiology and management. Paediatr Drugs 15: 311317.[Crossref] [Google Scholar]
  44. de Paula Machado DF, Martins T, Trevisol DJ, Vieira E, Silva RA, Narciso-Schiavon JL, Schuelter Trevisol F, Schiavon L de L, , 2013. Prevalence and factors associated with hepatitis B virus infection among senior citizens in a southern Brazilian city. Hepat Mon 13: e7874.[Crossref] [Google Scholar]
  45. Stepien M, Czarkowski MP, , 2013. Hepatitis B in Poland in 2011. Przegl Epidemiol 67: 239245. [Google Scholar]
  46. Bill CA, Summers J, , 2004. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 101: 1113511140.[Crossref] [Google Scholar]
  47. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, Flisiak R, Bock CT, Manns MP, Wedemeyer H, Cornberg M, , 2010. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 52: 514522.[Crossref] [Google Scholar]
  48. Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, , 2012. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion 52: 440446.[Crossref] [Google Scholar]
  49. Matsumoto C, Tadokoro K, Fujimura K, Hirakawa S, Mitsunaga S, Juji T, , 2001. Analysis of HBV infection after blood transfusion in Japan through investigation of a comprehensive donor specimen repository. Transfusion 41: 878884.[Crossref] [Google Scholar]
  50. Schmidt M, Nubling CM, Scheiblauer H, Chudy M, Walch LA, Seifried E, Roth WK, Hourfar MK, , 2006. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Vox Sang 91: 237243.[Crossref] [Google Scholar]
  51. Shouval D, , 2000. Is universal vaccination against hepatitis B sufficient for control of HBV infection? Lessons from the immunization campaign in Italy. J Hepatol 33: 10091011.[Crossref] [Google Scholar]
  52. Wait S, Chen DS, , 2012. Towards the eradication of hepatitis B in Taiwan. Kaohsiung J Med Sci 28: 19.[Crossref] [Google Scholar]
  53. Huang X, Hollinger FB, , 2014. Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review. J Viral Hepat 21: 153162.[Crossref] [Google Scholar]
  54. Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, Giuberti T, Orlandini A, Raffa G, Pollicino T, Raimondo G, Ferrari C, Missale G, , 2008. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 134: 14701481.[Crossref] [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0331
Loading
/content/journals/10.4269/ajtmh.15-0331
Loading

Data & Media loading...

Supplementary PDF

  • Received : 05 May 2015
  • Accepted : 05 Aug 2015
  • Published online : 09 Dec 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error